There were 1,506 press releases posted in the last 24 hours and 453,032 in the last 365 days.

Meningitis Infection Drug Pipeline Study, H2 2018 - Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline

/EIN News/ -- Dublin, Jan. 28, 2019 (GLOBE NEWSWIRE) -- The "Meningitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Meningitis" report has been added to's offering.

The Meningitis Infection pipeline guide presents complete overview of drugs currently being developed for Meningitis Infection. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Despite low costs of treatment, tetanus is rapidly progressing infectious disease, causing mortality. Fourteen companies are currently developing vaccines and treatment options against tetanus infections. The companies in global tetanus pipeline include- Beijing Minhai Biotechnology Co Ltd, BIKEN Corporation, Biological E Ltd, Cadila Healthcare Ltd, Daiichi Sankyo Company, GC Pharma- Korea, GlaxoSmithKline Plc, Indian Immunologicals Ltd, LG Chem Ltd, Olymvax Biopharmaceuticals Inc, Panacea Biotec Ltd, Sanofi, Serum Institute of India Ltd and Wockhardt Ltd.

Report Description:

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Meningitis Infection pipeline candidate.
Research and Development progress along with latest news related to each of the Meningitis Infection pipeline candidates is included.

Major companies participating in therapeutic development of Meningitis Infection are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.

Amid strong interest for cure of Meningitis Infection from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Meningitis Infection clinical and pre-clinical products.

The report assists in identifying potential upcoming companies and drugs in Meningitis Infection pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Key Topics Covered:

I. Key Findings

1. Companies Investing in Meningitis Infection Pipeline
Number of Companies with Meningitis Infection projects in pre-clinical Development
Number of Companies with Meningitis Infection projects in Clinical Development

2. Pipeline Candidates include
Meningitis Infection Pipeline Agents in pre- clinical/ Discovery stage of Development
Meningitis Infection Pipeline Agents in Clinical Development stage
Meningitis Infection Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs
Small molecules among the Meningitis Infection Pipeline agents

II. Insights into Meningitis Infection Pipeline -

1. Disease Overview
Introduction to Meningitis Infection
Symptoms and Causes of Meningitis Infection
Treatment or Prevention Options for Meningitis Infection
Other Details
2. Phase wise Pipeline Compounds
Meningitis Infection Pipeline- Pre-Clinical/ Discovery stage Drugs
Meningitis Infection Pipeline- Phase 1 stage Drugs
Meningitis Infection Pipeline- Phase 2 stage Drugs
Meningitis Infection Pipeline- Phase 3 stage Drugs
Meningitis Infection Pipeline- Pre-Registration stage Drugs
3. Company wise Meningitis Infection Pipeline Compounds
4. Meningitis Infection Pipeline by Mechanism of Action

III. Meningitis Infection Pipeline Compound Details

  • amphotericin B
  • MYC-053
  • VRT 001-C
  • VRT 001-M
  • VT-1129

Drug Details

1. Snapshot
Name of the Therapeutic Agent
Developing Company
Co-Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details

IV. Meningitis Infection Pipeline Company Briefs

  • Matinas BioPharma Holdings Inc
  • Olymvax Biopharmaceuticals Inc
  • Olymvax Biopharmaceuticals Inc
  • TGV Therapeutics
  • Venus Remedies
  • Venus Remedies
  • Viamet Pharmaceuticals Inc

V. Latest News and Developments in Global Meningitis Infection Pipeline Market

VI. Appendix

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs , Infectious Diseases Drugs